NCT04942600

Brief Summary

The purpose of this study is to better understand Functional Neurological Disorders (FND) by measuring movement timing and brain activity in patients with FND during deliberate movements and when expressing an 'intention' to move. This investigation will use non-invasive brain stimulation to investigate the role of the temporal-occipital-parietal junction in FND.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
19

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 11, 2021

Completed
17 days until next milestone

First Posted

Study publicly available on registry

June 28, 2021

Completed
7 months until next milestone

Study Start

First participant enrolled

January 14, 2022

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 29, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 29, 2022

Completed
Last Updated

March 31, 2023

Status Verified

March 1, 2023

Enrollment Period

7 months

First QC Date

June 11, 2021

Last Update Submit

March 29, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in relative timing of intention-to-act vs action production

    Assessment of change in the lag time between intended and actual action production during pointing and stimulus response tasks.

    1 hour: Immediately prior to and following one session of rTMS

  • Change in resting state activity in temporal-parietal junction brain region

    Assessment of changes in EEG brain activity readings when participants are at rest at various frequencies, primarily targeting delta/theta bands.

    1 hour: Immediately prior to and following one session of rTMS

Secondary Outcomes (2)

  • Change in brain activity related to 'intention to act'

    1 hour: Immediately prior to and following one session of rTMS

  • Change in brain activity related to motor production

    1 hour: Immediately prior to and following one session of rTMS

Study Arms (1)

Repetitive Transcranial Magnetic Stimulation (rTMS)

EXPERIMENTAL

1 session (3,000 pulses) of high-frequency (10Hz) repetitive stimulation applied over the right temporal parietal junction (TPJ) gyrus in individuals with Functional Neurological Disorder using a MagStim Rapid2 Transcranial Magnetic Simulation machine.

Device: MagStim Rapid2 Transcranial Magnetic Simulation

Interventions

A non-invasive method of brain stimulation

Repetitive Transcranial Magnetic Stimulation (rTMS)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Confirmed diagnosis of Functional Neurological Disorder with motor symptoms.

You may not qualify if:

  • Presence of another comorbid psychiatric disorder;
  • Any contraindication for rTMS (e.g., implanted metal devices; cardiac pacemaker or pacemaker wires; neurostimulators; implanted pumps, metal in the body \[rods, plates, screws, shrapnel, dentures, IUD\] or metallic particles in the body, surgical clips in the head, previous neurosurgery, cochlear implants, prosthetic heart valves);
  • Currently pregnant.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St. Boniface Hospital

Winnipeg, Manitoba, R2H2A6, Canada

Location

MeSH Terms

Conditions

Conversion Disorder

Condition Hierarchy (Ancestors)

Somatoform DisordersMental Disorders

Study Officials

  • Bruce Bolster, PhD

    University of Winnipeg

    PRINCIPAL INVESTIGATOR
  • Mandana Modirrousta, MD PhD

    University of Manitoba

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 11, 2021

First Posted

June 28, 2021

Study Start

January 14, 2022

Primary Completion

July 29, 2022

Study Completion

July 29, 2022

Last Updated

March 31, 2023

Record last verified: 2023-03

Locations